Advertisement
Screener

IQVIA HOLDINGS INC. (IQV) Net Cash Provided by (Used in) Investing Activities, Continuing Operations

2.6 / 5 stars · 61/118 Roast Me

IQVIA HOLDINGS INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations

IQVIA HOLDINGS INC. (IQV) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$120.00 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-04.

Discontinued › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-04

  • IQVIA HOLDINGS INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was -$120.00M.
  • IQVIA HOLDINGS INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was -$416.00M, a 122.95% decline year-over-year.
  • IQVIA HOLDINGS INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$334.00M.
  • IQVIA HOLDINGS INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$200.00M.
  • IQVIA HOLDINGS INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$1.19B, a 168.75% decline from fiscal 2016.
  • IQVIA HOLDINGS INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $1.73B.
  • IQVIA HOLDINGS INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$67.00M.
  • IQVIA HOLDINGS INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$173.00M.
Period endNet Cash Provided by (Used in) Investing Activities, Continuing Operations 3 monthNet Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month as first filedNet Cash Provided by (Used in) Investing Activities, Continuing Operations 6 monthNet Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filedNet Cash Provided by (Used in) Investing Activities, Continuing Operations 9 monthNet Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month as first filedNet Cash Provided by (Used in) Investing Activities, Continuing Operations 12 monthNet Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month as first filed
2018-03-31-$120.00M
10-Q · filed 2018-05-04
-$536.00M
derived: sum of 2 quarters · filed 2018-05-04
-$870.00M
derived: sum of 3 quarters · filed 2018-05-04
-$1.07B
derived: sum of 4 quarters · filed 2018-05-04
2017-12-31-$416.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16
-$750.00M
derived: sum of 2 quarters · filed 2018-02-16
-$950.00M
derived: sum of 3 quarters · filed 2018-02-16
-$1.19B
10-K · filed 2018-02-16
2017-09-30-$334.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27
-$534.00M
derived: sum of 2 quarters · filed 2017-10-27
-$774.00M
10-Q · filed 2017-10-27
$1.04B
derived: sum of 4 quarters · filed 2018-05-04
2017-06-30-$200.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04
-$440.00M
10-Q · filed 2017-08-04
$1.37B
derived: sum of 3 quarters · filed 2018-05-04
$1.35B
derived: sum of 4 quarters · filed 2018-05-04
2017-03-31-$240.00M
10-Q · filed 2018-05-04
$1.57B
derived: sum of 2 quarters · filed 2018-05-04
$1.55B
derived: sum of 3 quarters · filed 2018-05-04
$1.53B
derived: sum of 4 quarters · filed 2018-05-04
2016-12-31$1.81B
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16
$1.79B
derived: sum of 2 quarters · filed 2018-02-16
$1.77B
derived: sum of 3 quarters · filed 2018-02-16
$1.73B
10-K · filed 2018-02-16
2016-09-30-$22.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27
-$39.00M
derived: sum of 2 quarters · filed 2017-10-27
-$82.00M
10-Q · filed 2017-10-27
-$81.85M
10-Q · filed 2016-11-03
-$109.60M
derived: sum of 4 quarters · filed 2018-02-16
2016-06-30-$17.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04
-$60.00M
10-Q · filed 2017-08-04
-$59.56M
10-Q · filed 2016-07-27
-$87.60M
derived: sum of 3 quarters · filed 2018-02-16
-$81.53M
derived: sum of 4 quarters · filed 2018-02-16
2016-03-31-$43.00M
10-Q · filed 2017-05-08
-$43.47M
10-Q · filed 2016-05-03
-$70.60M
derived: sum of 2 quarters · filed 2018-02-16
-$64.53M
derived: sum of 3 quarters · filed 2018-02-16
-$91.69M
derived: sum of 4 quarters · filed 2018-02-16
2015-12-31-$27.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16
-$21.53M
derived: sum of 2 quarters · filed 2018-02-16
-$48.69M
derived: sum of 3 quarters · filed 2018-02-16
-$67.00M
10-K · filed 2018-02-16
-$66.95M
10-K · filed 2016-02-11
2015-09-30$6.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
-$21.09M
derived: sum of 2 quarters · filed 2016-11-03
-$39.40M
10-Q · filed 2016-11-03
-$66.47M
derived: sum of 4 quarters · filed 2017-02-16
2015-06-30-$27.16M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-27
-$45.47M
10-Q · filed 2016-07-27
-$72.54M
derived: sum of 3 quarters · filed 2017-02-16
-$185.46M
derived: sum of 4 quarters · filed 2017-02-16
2015-03-31-$18.31M
10-Q · filed 2016-05-03
-$45.38M
derived: sum of 2 quarters · filed 2017-02-16
-$158.30M
derived: sum of 3 quarters · filed 2017-02-16
-$177.33M
derived: sum of 4 quarters · filed 2017-02-16
2014-12-31-$27.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16
-$139.99M
derived: sum of 2 quarters · filed 2017-02-16
-$159.02M
derived: sum of 3 quarters · filed 2017-02-16
-$173.00M
10-K · filed 2017-02-16
-$173.11M
10-K · filed 2015-02-12
2014-09-30-$112.92M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-28
-$131.95M
derived: sum of 2 quarters · filed 2015-10-28
-$145.93M
10-Q · filed 2015-10-28
-$158.11M
derived: sum of 4 quarters · filed 2016-02-11
2014-06-30-$19.03M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29
-$33.01M
10-Q · filed 2015-07-29
-$45.19M
derived: sum of 3 quarters · filed 2016-02-11
-$205.78M
derived: sum of 4 quarters · filed 2016-02-11
2014-03-31-$13.98M
10-Q · filed 2015-04-29
-$26.16M
derived: sum of 2 quarters · filed 2016-02-11
-$186.75M
derived: sum of 3 quarters · filed 2016-02-11
-$213.96M
derived: sum of 4 quarters · filed 2016-02-11
2013-12-31-$12.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11
-$172.78M
derived: sum of 2 quarters · filed 2016-02-11
-$199.98M
derived: sum of 3 quarters · filed 2016-02-11
-$236.18M
10-K · filed 2016-02-11
-$240.18M
10-K · filed 2014-02-13
2013-09-30-$160.59M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30
-$187.80M
derived: sum of 2 quarters · filed 2014-10-30
-$223.99M
10-Q · filed 2014-10-30
-$227.99M
10-Q · filed 2013-10-31
-$236.56M
derived: sum of 4 quarters · filed 2015-02-12
2013-06-30-$27.21M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31
-$63.40M
10-Q · filed 2014-07-31
-$67.40M
10-Q · filed 2013-08-01
-$75.96M
derived: sum of 3 quarters · filed 2015-02-12
-$132.68M
derived: sum of 4 quarters · filed 2015-02-12
2013-03-31-$36.19M
10-Q · filed 2014-05-01
-$48.76M
derived: sum of 2 quarters · filed 2015-02-12
-$105.47M
derived: sum of 3 quarters · filed 2015-02-12
-$146.93M
derived: sum of 4 quarters · filed 2015-02-12
2012-12-31-$12.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12
-$69.28M
derived: sum of 2 quarters · filed 2015-02-12
-$110.73M
derived: sum of 3 quarters · filed 2015-02-12
-$132.23M
10-K · filed 2015-02-12
2012-09-30-$56.71M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31
-$98.17M
derived: sum of 2 quarters · filed 2013-10-31
-$119.67M
10-Q · filed 2013-10-31
2012-06-30-$41.46M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01
-$62.96M
10-Q · filed 2013-08-01
2012-03-31-$21.50M
10-Q · filed 2013-05-14
2011-12-31-$224.84M
10-K · filed 2014-02-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
INCYTE CORP (INCY)United States$24.855B13.14
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B